Localization, Characterization, and Second Messenger Coupling of Pituitary Adenylate Cyclase-Activating Polypeptide Receptors in the Fetal Human Adrenal Gland during the Second Trimester of Gestation*

Autor: L, Yon, L, Breault, V, Contesse, G, Bellancourt, C, Delarue, A, Fournier, J G, Lehoux, H, Vaudry, N, Gallo-Payet
Přispěvatelé: Neuroendocrinologie cellulaire et moléculaire, Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Fédératif de Recherches Multidisciplinaires sur les Peptides (IFRMP 23), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Université Le Havre Normandie (ULH), Normandie Université (NU)-CHU Rouen, Normandie Université (NU)-Centre National de la Recherche Scientifique (CNRS), Faculté de médecine et des sciences de la santé [Sherbrooke] (UdeS), Université de Sherbrooke (UdeS), Université du Québec à Montréal = University of Québec in Montréal (UQAM), Institut Armand Frappier (INRS-IAF), Institut National de la Recherche Scientifique [Québec] (INRS)-Réseau International des Instituts Pasteur (RIIP), This work was supported by the Medical Research Council of Canada (MRC MT13679, to N.G.-P. and J.-G.L.), the Institut National de la Santé et de la Recherche Médicale (INSERM U413), a France-Québec exchange programme (Coopération Scientifique et Technologique Franco-Québécoise (PVP-73–9, to N.G.-P. and H.V.), and the Conseil Régional de Haute-Normandie., The authors would like to thank Ms. Huguette Lemonnier (INSERM U413) and Lucie Chouinard (Service of Endocrinology, Sherbrooke) for skillful technical assistance. We appreciate the advice from Drs. Magali Basille and Bruno Gonzalez (INSERM U413) for autoradiography.
Jazyk: angličtina
Rok vydání: 1997
Předmět:
MESH: Receptors
Pituitary Hormone/metabolism

[SDV]Life Sciences [q-bio]
Receptors
Pituitary Adenylate Cyclase-Activating Polypeptide

MESH: Logistic Models
Second Messenger Systems
Embryonic and Fetal Development
MESH: Autoradiography
MESH: Pregnancy
Pregnancy
MESH: Analysis of Variance
Adrenal Glands
Humans
Receptors
Pituitary Hormone

Cells
Cultured

MESH: Embryonic and Fetal Development/physiology
Analysis of Variance
MESH: Receptors
Pituitary Adenylate Cyclase-Activating Polypeptide

MESH: Second Messenger Systems/physiology
MESH: Humans
MESH: Adrenal Glands/metabolism
MESH: Adrenal Glands/embryology
Logistic Models
Pregnancy Trimester
Second

MESH: Pregnancy Trimester
Second

MESH: Receptors
Pituitary Adenylate Cyclase-Activating Polypeptide
Type I

Autoradiography
Female
MESH: Female
Receptors
Pituitary Adenylate Cyclase-Activating Polypeptide
Type I

MESH: Cells
Cultured
Zdroj: The Journal of clinical endocrinology and metabolism
The Journal of clinical endocrinology and metabolism, Williams & Wilkins Co., 1997, 83 (4), pp.1299-1305. ⟨10.1210/jcem.83.4.4690⟩
Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 1998, 83 (4), pp.1299-1305. ⟨10.1210/jcem.83.4.4690⟩
ISSN: 0021-972X
1945-7197
DOI: 10.1210/jcem.83.4.4690⟩
Popis: International audience; The distribution and pharmacological properties of pituitary ad-enylate cyclase-activating polypeptide (PACAP) receptors were studied in the fetal human adrenal gland during the second trimester of gestation. Autoradiographic studies, using [ 125 I]PACAP27 as a ra-dioligand, revealed that PACAP-binding sites are exclusively located on chromaffin cells of adrenals from fetuses 14 –20 weeks old. Biochemical characterization of binding revealed the occurrence of a single class of PACAP-binding sites with a dissociation constant value of 0.32– 0.74 nmol/L and a binding capacity of 0.30 – 0.81 pmol/mg wet tissue. PACAP27 and PACAP38 were equipotent in competing for [ 125 I]PACAP27 binding (IC 50 0.28 – 0.64 nmol/L and 0.15– 0.81 nmol/L, respectively), and the Hill coefficients were close to 1. In contrast, vasoactive intestinal polypeptide was much less efficient in displacing the tracer (IC 50 4 –362 nmol/L), and the Hill coefficients were less than 0.6. PACAP38 induced a dose-dependent increase in cAMP production in fetal human adrenal cell suspension (ED 50 0.07 0.02 nmol/L), as well as in cells maintained in culture for 5 days (5.4 1.8 nmol/L). In constrast, PACAP38 induced a modest increase in inositol phosphate formation. These data indicate that type I PACAP receptors are present in the early stages of the human me-dulla organization during the process of migration of chromaffin cells from the periphery to the central part of the gland. The present results suggest that PACAP could be involved in the regulation of the human adrenochromaffin cells during ontogenesis. (J Clin Endocrinol Metab 83: 1299 –1305, 1998)
Databáze: OpenAIRE